NEoAdjuvant radiohormonal therapy versus standard of care for oligometastatic prostate cancer (NEAR-TOP): study protocol of a multicenter, open-label, randomised controlled trial

Abstract Background Metastatic prostate cancer is commonly treated with androgen deprivation therapy (ADT) and chemotherapy, which often leads to treatment resistance and disease progression with limited effective interventions. Recent advances in robotic surgery and precision radiotherapy have prom...

Full description

Bibliographic Details

Published in:	BMC Cancer
Main Authors:	Zhiguo Fan, Duocai Li, Shi Yan, Xianzhi Zhao, Lei Yin, Weidong Xu, Ye Wang, Huojun Zhang, Yifan Chang, Shancheng Ren
Format:	Article
Language:	English
Published:	BMC 2025-04-01
Subjects:	Oligometastatic prostate cancer Preoperative radiotherapy Robotic-assisted Radical prostatectomy Endocrine therapy Prognosis
Online Access:	https://doi.org/10.1186/s12885-024-13201-w